{"id":3992,"date":"2021-03-26T23:08:04","date_gmt":"2021-03-26T23:08:04","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3992"},"modified":"2021-03-26T23:08:10","modified_gmt":"2021-03-26T23:08:10","slug":"cubas-vaccine-revolution-the-island-of-freedom-developing-whopping-five-anti-covid-jabs","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cubas-vaccine-revolution-the-island-of-freedom-developing-whopping-five-anti-covid-jabs\/","title":{"rendered":"Cuba’s Vaccine Revolution: The Island of Freedom Developing Whopping Five Anti-COVID Jabs"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

While the EU is struggling to stockpile enough anti-COVID jabs, Cuba, a small Caribbean island nation surviving a decades-long US trade embargo, kicked off Phase 3 testing of its own vaccine coronavirus candidates, Soberana 02 and Abdala, earlier this month.<\/strong><\/p>\n\n\n\n

Cuba is developing five anti-COVID vaccines. Three of them, Soberana 01, Soberana 02 and Soberana Plus, are being made by the Finlay Institute for Vaccines (IFV). The other two, Abdala and Mambisa, are brainchildren of the Centre for Genetic Engineering and Biotechnology (CIGB).<\/p>\n\n\n\n

The definitive advantage of the Cuban jabs is that they do not require additional refrigeration requirements: they can be kept at temperatures ranging from 2C to 8C, which considerably simplifies their transportation and storage. Soberana 02 and Adbala are regarded as the most advanced among Cuban vaccine candidates.<\/p>\n\n\n\n

Soberana 02<\/h2>\n\n\n\n

Testing of Soberana 02, Spanish for “sovereignty,” is nearing completion: on Monday, the nation’s bio-pharmaceutical group, BioCubaFarma, announced<\/a> the beginning of intervention studies with workers from Finlay Vaccines Institute (IFV) and Molecular Immunology Centre (CIM).<\/p>\n\n\n\n

On March 3, the Centre for State Control of Drugs, Equipment and Medical Devices (CECMED) green-lighted the Phase 3 testing of the vaccine. Two weeks later, Granma, the official newspaper of the Central Committee of the Cuban Communist Party, reported<\/a> that the initial stage of Soberana 02’s Phase 3 clinical trials had been completed “satisfactorily, in strict compliance with the established protocol and best clinical practices.”<\/p>\n\n\n\n

Earlier in January, the Cuban government\u00a0pledged<\/a>\u00a0to produce 100 million doses of Soberana 02 in 2021 to meet its own demand and that of other countries: Vietnam, Iran, Venezuela, Pakistan and India. Other nations have already signaled their interest in obtaining the drug.<\/p>\n\n\n\n

\n

Cuba is conducting clinical trials for two vaccine candidates with plans to produce 100 million doses, distributed for free to all Cubans and exported to Latin America and Asia. pic.twitter.com\/yuIZYBvT9v<\/a><\/p>— Belly of The Beast (@bellybeastcuba) January 29, 2021<\/a><\/blockquote>